ESC
BSX icon

Eurizon SLJ Capital’s Boston Scientific BSX Stock Holding History

Eurizon SLJ Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$76.3K Hold
1,787
– – 0.03% 164
2026
Q1 		$112K Buy
+1,787
New +$143K 0.05% 149

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Eurizon SLJ Capital's BSX Position: Q2 2026 in Review

Eurizon SLJ Capital held its Boston Scientific (BSX) position steady in Q2 2026 at 1,787 shares worth $76.3K. The position accounts for 0.03% of the portfolio, ranked #164.

Eurizon SLJ Capital first reported a position in BSX in Q1 2026 and has held it in 2 quarters since. The position peaked at $112K in Q1 2026. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Eurizon SLJ Capital held 1,787 shares of Boston Scientific worth $76.3K as of Q2 2026.
  • Eurizon SLJ Capital left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up 0.03% of Eurizon SLJ Capital's portfolio in Q2 2026, its #164 holding.
  • Eurizon SLJ Capital first reported a position in Boston Scientific in Q1 2026 and has held it in 2 quarters since.
  • Eurizon SLJ Capital's Boston Scientific position peaked at $112K in Q1 2026.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Eurizon SLJ Capital's 13F filing for Q2 2026, filed 3 Aug 2026.